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Evaluation of Anisole-Substituted Boron Difluoride Formazanate 
Complexes for Fluorescence Cell Imaging 
Ryan R. Maar,[a,b] Stephanie M. Barbon,[a,b]  Neha Sharma,[a]  Hilary Groom,[c]  Leonard G. Luyt,*[a,c,d]  
and Joe B. Gilroy*[a,b] 
Abstract: The evaluation of three subclasses of boron difluoride 
formazanate complexes bearing o-, m-, and p-anisole N-aryl 
substituents (Ar) as readily accessible alternatives to boron 
dipyrromethene (BODIPY) dyes for cell imaging applications is 
described. While the wavelengths of maximum absorption (max) and 
emission (em) observed for each subclass of complexes, which 
differed by their carbon-bound substituents (R), were similar, the 
emission quantum yields for 7ac (R = cyano) were enhanced 
relative to 8ac (R = nitro) and 9ac  (R = phenyl). Complexes 7ac 
and 8ac were also significantly easier to reduce electrochemically 
to their radical anion and dianion forms compared to 9ac. Within 
each subclass, the o-substituted derivatives were more difficult to 
reduce, had shorter max and em, and lower emission quantum yields 
than the p-substituted analogs as a result of sterically-driven twisting 
of the N-aryl substituents and a decrease in the degree of  
conjugation. The m-substituted complexes were the least difficult to 
reduce and possessed intermediate max, em, and quantum yields. 
The complexes studied also exhibited large Stokes shifts (82152 
nm, 21435483 cm
1
). Finally, the utility of complex 7c (Ar = p-
anisole, R = cyano), which can be prepared for just a few dollars per 
gram, for fluorescence cell imaging was demonstrated. The use of 
7c and 4',6-diamino-2-phenylindole (DAPI) allowed for simultaneous 
imaging of the cytoplasm and nucleus of mouse fibroblast cells. 
Introduction 
   Boron difluoride (BF2) chelates of N-donor ligands are among 
the most widely studied classes of molecular materials due to 
their unique, tunable, and potentially useful absorption, emission, 
and electrochemical properties.[1],[2] These compounds, including 
the ubiquitous boron dipyrromethanes (BODIPYs) 1,[3] have 
shown utility as sensors,[4],[5] as efficient 
electrochemiluminescence luminophores,[6],[7] as the functional 
component of organic electronics,[8] in photodynamic 
therapy,[9],[10] and perhaps most commonly, as fluorescence cell 
imaging agents.[11],[12] Despite their widespread use in a broad 
range of applications, further development of the chemistry of 
many BF2 complexes has often been limited by their challenging 
synthesis and/or substantial cost. For example, a few milligrams 
of commercially available BODIPYs for cell imaging applications 
will often cost several hundred US dollars. Considering these 
factors, there remains a significant need for readily accessible 
molecular materials with similar or improved properties 
compared to BODIPYs that may be prepared via relatively 
simple, low-cost synthetic pathways. 
   BF2 formazanate complexes meet these criteria and offer the 
ability to tune spectroscopic and electrochemical properties 
through structural variation.[13] The parent formazans 2,[14] known 
primarily for their use in cell viability assays,[15] are typically 
prepared using aryl diazonium coupling reactions in aqueous 
media. They exist in three different conformations (i.e., 'closed', 
'open', or 'linear') depending on the carbon-bound substituent 
(R) present.[14a, 16] In recent years, the coordination chemistry of 
formazanate ligands 3 has received significant attention due to 
the rich spectroscopic and redox properties exhibited by the 
resulting complexes.[17],[18] However, their utility in practical 
applications such as cell imaging has not been demonstrated. 
 
 
 
 
 
 
   Herein, taking inspiration from the biocompatibility of 
formazans, we present a study designed to evaluate a series of 
anisole-substituted BF2 formazanate complexes (Ar = o-anisole, 
m-anisole, p-anisole; R = cyano, nitro, phenyl) in an effort to 
showcase their utility as fluorescence cell imaging agents. 
Results and Discussion 
Synthesis 
 
Anisole-substituted formazans 4ac, 5ac, and 6ac were 
prepared by adapting established procedures for the coupling of 
aryl diazonium salts and activated methylenes such as 
cyanoacetic acid, nitromethane, and phenylpyruvic acid in yields 
ranging from 1890%.[16, 19] It is worth noting that the variability in 
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reaction yields relates mainly to the unpredictable stability of the 
aryl diazonium salts involved.[20] 3-Cyanoformazans 4bd exist 
primarily in the 'open' conformation in solution due to the 
presence of a linear carbon-bound cyano substituent and were 
identified by their characteristic orange color [wavelength of 
maximum absorption (max): 419453 nm] and the chemical shift 
of the 1H NMR resonance originating from their NH protons (δ: 
11.7512.89). All other formazans produced during this study 
exist in the more common 'closed' conformation in solution and 
exhibit characteristic NH resonances in their 1H NMR spectra 
between 13.91 and 15.56 ppm and max values between 448 and 
530 nm in their UV-vis absorption spectra.  
   BF2 formazanate complexes 7ad, 8ac, and 9ac were 
prepared by heating the appropriate formazan in toluene with an 
excess of triethylamine and boron trifluoride diethyl etherate 
(Scheme 1, Table 1, Figures S1S36). The isolated yields for 
the complexes ranged from 1591% and were highly dependent 
on the purification methods employed. All new BF2 formazanate 
complexes were fully characterized by 1H, 11B, 13C, and 19F NMR 
spectroscopy, UV-vis absorption and emission spectroscopy, IR 
spectroscopy, and high-resolution mass spectrometry. The 
formation of the BF2 complexes was accompanied by the 
disappearance of the NH resonance in their 1H NMR spectra, 
and the appearance of a 1:2:1 triplet and a 1:1:1:1 quartet in 
their 11B and 19F NMR spectra, respectively. With the exception 
of 7a (Ar = o-anisole, R = cyano), the BF2 complexes were 
stable towards hydrolysis. In the presence of 10 equivalents of 
water, complex 7a slowly hydrolyzed to re-form the parent 
formazan 4a (4% degradation after 48 h, 8% degradation after 
96 h). By comparison, complex 7d (Ar = o-ethylbenzene, R = 
cyano) was indefinitely stable towards hydrolysis under the 
same conditions. Based on this comparison, we conclude that 
the hydrolysis of 7a is not driven by steric interactions alone, but 
rather that the lone pairs on oxygen likely play an important role 
in the decomposition pathway. Furthermore, the presence of the 
linear carbon-bound cyano substituent in 7a may facilitate its 
decomposition as it potentially allows for 'open' and 'linear' 
ligand arrangements to be accessed. Similar ligand orientations 
are less likely for reaction intermediates derived from complexes 
8a and 9a, which possess non-linear nitro and phenyl carbon-
bound substituents.  
X-ray Crystallography 
Single crystals of complexes 7a and 7b suitable for X-ray 
diffraction studies were grown by slow evaporation of saturated 
dichloromethane solutions in a sealed vessel containing 
hexanes. In the solid-state 7a and 7b exist in 'dragonfly' 
conformations, with the nitrogen-nitrogen and carbon-nitrogen 
bond lengths of the formazanate ligand backbone falling 
between those typically associated with single and double bonds 
of the same atoms (Figure 1, Table 2).[21] The N-aryl substituents 
are bent out of plane relative to the N4 backbone of the 
formazanate ligands by an average torsion angle of 61.2 and 
47.7 for 7a and 7b, respectively. The boron atoms reside 0.54 
and 0.50 Å out of the N4 plane in the structures of 7a and 7b.  
 
 
 
 
 
 
 
Scheme 1. General synthetic approach for the synthesis of BF2 formazanate 
complexes 7bd (a) and BF2 formazanate complexes 7a, 8ac and 9ac (b). 
See Table 1 for a detailed list of substituents. 
 
Table 1. Substituents for formazans 4ad, 5ac, and 6ac and BF2 
formazanate complexes 7ad, 8ac, and 9ac. 
 
Compound Ar R 
4a/7a o-anisole cyano 
4b/7b m-anisole cyano 
4c/7c p-anisole cyano 
4d/7d o-ethylbenzene cyano 
5a/8a o-anisole nitro 
5b/8b m-anisole nitro 
5c/8c p-anisole nitro 
6a/9a o-anisole phenyl 
6b/9b m-anisole phenyl 
6c/9c p-anisole phenyl 
These values are substantially larger than the torsion angles of 
18.3 and 37.1 and boron displacements of 0.13 and 0.34 Å 
observed for the two crystallographically independent forms of 
7c.[13b] Initially, we were tempted to rationalize these trends 
through steric arguments, whereby interactions between the o-, 
and to a lesser extent, m-methoxy groups and the fluorine atoms 
may lead to twisting of the N-aryl substituents relative to the 
formazanate backbone. While this interpretation appears to hold 
true for 7a (Ar = o-anisole, R = cyano), the large torsion angles 
observed for 7b (Ar = m-anisole, R = cyano) likely arise due to 
crystal packing effects including slipped -stacking interactions 
(Figure S37). This conclusion is further corroborated by the fact 
that the methoxy substituents are anti to the BF2 moiety in the 
solid-state structure of 7b. 
Cyclic Voltammetry 
The electrochemical properties of BF2 complexes 7ac were 
studied using cyclic voltammetry (Figure 2 and S38, Table 3). 
Each complex underwent two reversible one-electron reductions 
to form the corresponding ligand-centered radical anion and 
dianion (Scheme 2), while 7c was the only complex in the series 
that was oxidized (irreversibly) within the electrochemical 
window offered by acetonitrile. We have previously shown that 
electron-donating N-aryl substituents render BF2 formazanate  
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Figure 1. Solid-state structures of complexes 7a (a) and 7b (b). Anisotropic 
displacement ellipsoids are shown at 50% probability and hydrogen atoms 
have been omitted for clarity. 
 
Table 2. Selected bond lengths (Å) and angles (deg) for BF2 formazanate 
complexes 7ac. 
 
 7a 7b 7c
[a], 
 
N1−N2 1.3040(16) 1.2987(6) 1.307(2) 1.306(2) 
N3−N4 1.3038(16) − 1.304(2) 1.302(2) 
C1−N2 1.3404(19) 1.3443(5) 1.340(3) 1.335(3) 
C1−N4 1.3438(18) − 1.335(3) 1.340(3) 
N1−N2−C1 116.09(11) 116.42(4) 116.75(18) 116.21(17) 
N1−B1−N3 101.99(10) − 106.85(17) 104.75(16) 
N1−B1−N1´ − 102.63(5) − − 
N2−C1−N4 126.85(12) − 130.0(2) 129.32(18) 
N2´−C1−N2 − 127.22(6) − − 
boron 
displacement
[b]
 
0.54 0.50 0.13 0.34 
dihedral angles
[c]
 62.0, 60.5 47.7, 47.7 15.3, 21.4 37.6, 36.6 
[a]
 
The asymmetric unit determined for BF2 complex 7c contains two unique 
molecules. [b]
 
Distance between B1 and the N4 plane. [c]
 
Torsion angle 
between N1 and N3 aryl substituents and the N4 plane. 
 
complexes more difficult to reduce than the phenyl-substituted 
analogs, and that the opposite is true for complexes bearing 
electron-withdrawing substituents.[13b, c] In the present study, the 
interpretation is slightly more complex as both steric and 
electronic effects must be considered. Complexes 7a and 7c 
possess anisole substituents with o- and p-substitution patterns, 
which potentially allow for resonance donation of oxygen lone 
pairs leading to extended  conjugation of the formazanate 
framework. The m-substituted complex 7b is not resonance 
delocalized, and should therefore possess properties purely 
associated with the inductive electron-withdrawing character of 
the methoxy group. Indeed, 7b is the easiest complex to reduce 
within the series (Ered1 = 0.50 V; Ered2 = 1.62 V vs. 
ferrocene/ferrocenium). The o-substituted complex 7a was 
observed to be more difficult to reduce (Ered1 = 0.73 V; Ered2 = 
1.88 V) than the p-substituted complex 7c (Ered1 = 0.68 V; 
Ered2 = 1.82 V). We attribute this behavior to twisting of the o-
anisole substituents relative to the formazanate backbone in 7a 
in solution. This twisting, which is consistent with the solid-state 
structure described above, limits the degree of  conjugation of 
the formazanate framework. The reduced degree of  
conjugation results in destabilization of the lowest unoccupied 
molecular orbital (LUMO), and, in turn, renders 7a more difficult 
to reduce than the  conjugated complex 7c. This argument is 
supported by DFT studies that showed the LUMO orbital of 
closely related complexes to include both the formazanate 
backbone and N-aryl substituents.[13b, 13d] In order to confirm that 
the effect of the substituent pattern on the electrochemical 
properties of anisole-substituted BF2 formazanate complexes 
was general, cyclic voltammograms were also collected for 8ac 
(R = nitro) and 9ac (R = phenyl) (Figures S39 and S40, Table 
3). Nitro-substituted complexes 8ac were slightly easier to 
reduce than the corresponding cyano-substituted complexes 
due to the strong electron-withdrawing nature of the nitro group, 
while phenyl-substituted complexes 9ac were much more 
difficult to reduce due to the absence of a strongly electron-
withdrawing carbon-bound substituent on the formazanate 
backbone. For each series, the m-substituted complexes were 
the easiest to reduce and the o-substituted complexes were 
more difficult to reduce than the p-analogs, confirming that the 
trend discussed above is general. 
 
Figure 2. Cyclic voltammograms for BF2 formazanate complexes 7a (Ar = o-
anisole, R = cyano), 7b (Ar = m-anisole, R = cyano), and 7c (Ar = p-anisole, R 
= cyano) recorded in dry, degassed acetonitrile containing ~1 mM analyte and 
0.1 M n-Bu4NPF6 at a scan rate of 100 mV s
1. 
 
 
 
 
 
 
 
 
 
 
Scheme 2. Electrochemical reduction of BF2 formazanate complexes 7a, 7b, 
and 7c (Ar = o-anisole, m-anisole, or p-anisole). 
 
a
b
-3 -2.5 -2 -1.5 -1 -0.5 0 0.5
Potential (V vs. Ferrocene / Ferrocenium)
50 μA 7a
7b
7c
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UV-vis Absorption and Emission Spectroscopy 
 
The UV-vis absorption and emission spectra for BF2 complexes 
7ac (R = cyano) are shown in Figure 3 and the data 
summarized in Table 3. Each of the complexes is strongly 
absorbing within the visible region of the electromagnetic 
spectrum with wavelengths of maximum absorption (max) 
ranging from 467 to 572 nm and molar extinction coefficients () 
ranging from 16,000 to 42,700 M−1 cm−1 in toluene. The low-
energy absorption maxima for a similar set of complexes was 
shown by time-dependent DFT to involve primarily the highest 
occupied molecular orbital (HOMO)-LUMO transition.[13d] The 
same series of compounds exhibited wavelengths of maximum 
emission (em) ranging from 592 to 656 nm and quantum yields 
(f) ranging from 0.05 to 0.77. As a result of the twisted 
conformation adopted by the N-aryl substituents, and the 
reduced degree of  conjugation that results, the o-substituted 
complex 7a had the lowest values of max (467 nm),  (16,000 
M−1 cm−1), em (592 nm), and f (0.05). Conversely, p-substituted 
complex 7c possessed properties consistent with extended  
conjugation arising from the relatively coplanar orientation of the 
N-aryl substituents and the formazanate backbone (max = 572 
nm;  = 42,700 M−1 cm−1; em = 656 nm; and f = 0.77). The 
spectroscopic characteristics of the m-substituted analog 7b fall 
between those observed for 7a and 7c and are dictated by the 
presence of the inductively electron-withdrawing methoxy group 
(max = 525 nm;  = 21,100 M
−1 cm−1; em = 635 nm; and f = 
0.13). Complex 7d, which has o-ethylbenzene N-aryl 
substituents, has max = 436 nm and  = 14,000 M
1 cm1,  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
confirming that the twisted structure postulated for 7a is not 
unique to anisole-substituted compounds, and is driven by steric 
interactions (Figure S42). The spectroscopic properties  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. UV-vis absorption spectra (a) and emission spectra (b) for BF2 
formazanate complexes 7a (Ar = o-anisole, R = cyano), 7b (Ar = m-anisole, R 
= cyano), and 7c (Ar = p-anisole, R = cyano) recorded for degassed 10 M 
toluene solutions.  
Table 3. Solution characterization data for BF2 complexes 7ad, 8ac, and 9ac. 
 
 solvent 
max 
(nm) 
  
(M
−1 
cm
−1
) 
em 
(nm) 
f
a ST  
(nm) 
ST  
(cm
−1
) 
Ered1
b  
(V) 
Ered2
b  
(V) 
R = cyano 
7a THF 456 10,100 590 0.03 134 4981  
(Ar = o-anisole) CH2Cl2 466 15,500 589 0.04 123 4481 −0.73 −1.88 
 toluene 467 16,000 592 0.05 125 4521   
7b THF 510 20,000 639 0.01 129 3958   
(Ar = m-anisole) CH2Cl2 517 18,500 637 0.03 120 3644 −0.50 −1.62 
 toluene 525 21,100 635 0.13 110 3300   
7c
[13b]
 THF 556 33,400 662 0.46 106 2880   
(Ar = p-anisole) CH2Cl2 558 35,300 661 0.65 103 2793 −0.68 −1.82 
 toluene 572 42,700 656 0.77 84 2239   
7d THF 433 12,000 562 0.01 129 5301   
(Ar = o-ethylbenzene) CH2Cl2 431 14,300 562 0.02 131 5408 −0.66 −1.86 
 toluene 436 14,000 565 0.02 129 5236   
R = nitro 
8a THF 456 5,900 608 0.03 152 5483   
(Ar = o-anisole) CH2Cl2 466 7,100 599 0.03 133 4768 −0.71 −1.83 
 toluene 468 7,500 603 0.05 135 4784   
8b THF 512 17,700 656 <0.01 144 4287   
(Ar = m-anisole) CH2Cl2 511 18,300 651 <0.01 140 4209 −0.43 −1.54 
 toluene 533 18,400 644 0.04 111 3234   
8c THF 559 26,700 667 0.17 108 2897   
(Ar = p-anisole) CH2Cl2 564 20,100 665 0.24 101 2693 −0.60 −1.72 
 toluene 572 23,600 661 0.33 82 2143   
R = phenyl 
9a THF 459 18,900 592 <0.01 133 4895   
(Ar = o-anisole) CH2Cl2 464 21,600 588 0.01 124 4545 −1.09 −1.97 
 toluene 467 18,800 596 <0.01 129 4635   
9b THF 520 25,000 643 <0.01 123 3679   
(Ar = m-anisole) CH2Cl2 521 25,000 644 0.025 123 3666 −0.81 −1.87 
 toluene 530 22,900 644 0.012 114 3340   
9c THF 548 23,400 672 0.019 124 3367   
(Ar = p-anisole) CH2Cl2 545 29,300 670 0.063 125 3423 −0.94 −1.93 
 toluene 551 25,500 672 0.028 121 3268   
a
Quantum yields were determined according to a published protocol
[22a]
 using ruthenium tris(bipyridine) hexafluorophosphate as a relative standard
[22b]
 and 
corrected for wavelength-dependent detector sensitivity (Figure S41). 
b
Cyclic voltammograms were recorded in dry, degassed acetonitrile containing ~1 mM 
analyte and 0.1 M n-Bu4NPF6 at a scan rate of 100 mV s
1 and internally referenced relative to the ferrocene/ferrocenium redox couple. 
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observed for complexes 8ac (R = nitro) and 9ac (R = phenyl) 
were closely related to those of 7ac, further demonstrating the 
generality of the trend observed (Figures S43 and S44). 
However, it must be noted that the emission quantum yields 
calculated for 8ac and 9ac, were lower than those calculated 
for 7ac. In particular, 9ac are weakly emissive, likely as a 
result of non-radiative decay pathways associated with the 
carbon-bound phenyl substituent. Each of the anisole-
substituted BF2 complexes reported in this study exhibited large 
Stokes shifts (ST) ranging from 82 to 152 nm (21435483 cm
1). 
This key characteristic of BF2 formazanate complexes is of 
significant importance to their potential use as fluorescence cell 
imaging agents, where photon re-absorption greatly limits 
emission intensity. 
 
Cell Imaging 
 
Based on our evaluation of the anisole-substituted BF2 
formazanate complexes described above, we concluded that 
complex 7c, which can be prepared in two straightforward 
synthetic steps involving minimal bench time for just a few 
dollars per gram, was an excellent candidate for fluorescence 
cell-imaging studies. To this end, the uptake of complex 7c into 
fibroblast cells was investigated (Figure 4). 
   Mouse fibroblast cells were incubated with 7c for one hour, 
and after washing and fixing, were imaged by confocal 
fluorescence microscopy.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The fluorescence images demonstrated that 7c was internalized 
by the fibroblast cells (Figure 4a,b). As a result of the low-energy 
(em ~660 nm) emission of 7c, this dye proved to be well suited 
for orthogonal imaging applications. We explored this potential 
by co-staining cells with the nuclear dye 4',6-diamidino-2-
phenylindole (DAPI), and demonstrated that 7c and DAPI could 
be used to image the cell cytoplasm and nucleus simultaneously 
(Figure 4c,d). During the course of these studies, we frequently 
observed punctate staining, which could be due to the dye being 
localized in either the endoplasmic reticulum and/or vesicles. 
Aggregation of the dye could be another possible explanation for 
the punctate appearance. However, we were able to rule out 
aggregation induced emission enhancement by adding water to 
tetrahydrofuran solutions of 7c, and demonstrating that emission 
intensity decreases as the volume fraction of water is increased 
and aggregates begin to form (Figure S45). We therefore 
conclude that the punctate staining is due to high local 
concentration of 7c rather than aggregation. 
Conclusions 
We have systematically evaluated a library of o-, m-, and p-
anisole-substituted BF2 formazanate complexes, and, for the first 
time, demonstrated their potential as readily accessible 
fluorescence imaging agents. The substitution pattern for each 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Confocal fluorescence micrographs of mouse fibroblast cells stained with BF2 formazanate complex 7c and DAPI. Images (a) and (b) were 
visualized with excitation at 559 nm and emission collected between 625725 nm. Images (c) and (d) are an overlay of images (a) and (b) with those 
obtained from excitation at 405 nm and emission collected between 425475 nm. 
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subset of complexes (R = cyano, nitro, and phenyl) was shown 
to have a dramatic effect on their electrochemical and 
spectroscopic properties. In each case, the o-substituted 
complexes were the most difficult to reduce electrochemically, 
had the shortest max and em, and possessed low emission 
quantum yields due to limited  conjugation of the formazanate 
framework. By comparison, the p-substituted analogs were 
slightly easier to reduce electrochemically, had dramatically red-
shifted max and em, and significantly enhanced emission 
quantum yields (up to 0.77). Each of these traits were consistent 
with extended  conjugation between the formazanate backbone 
and the N-aryl substituents. The spectroscopic properties of the 
m-substituted complexes, which were the easiest to reduce, 
were intermediate between those of the o- and p- complexes, 
due to the absence of resonance delocalization of the oxygen 
lone pairs and the inductive electron withdrawing nature of the 
methoxy groups. Based on our evaluation, we were able to 
identify complex 7c (Ar = p-anisole, R = cyano) as a strong 
candidate for use in fluorescence cell imaging applications. We 
subsequently demonstrated its efficacy as a fluorescent dye for 
orthogonal imaging of the cytoplasm (complex 7c) and nucleus 
(DAPI) of mouse fibroblast cells. Our future work in this area will 
expand on these results and focus on cell imaging applications 
involving disease-targeting BF2 formazanate dyes. 
Experimental Section 
General Considerations 
 
All reactions were carried out under nitrogen atmosphere using standard 
Schlenk techniques unless otherwise stated. Reagents were purchased 
from Sigma-Aldrich or Alfa Aesar and used as received. Solvents were 
purchased from Caledon Laboratories, dried using an Innovative 
Technologies Inc. solvent purification system, collected under vacuum, 
and stored under inert (nitrogen) atmosphere containing 4 Å molecular 
sieves. The synthesis and characterization of compounds 4c and 7c 
have been reported previously.[13b] NMR spectra were recorded on 400 
MHz (1H: 399.8 MHz, 11B: 128.3 MHz, 19F: 376.1MHz) or 600 MHz (1H: 
599.5 MHz, 13C: 150.8 MHz) Varian INOVA spectrometers. 1H NMR 
spectra were referenced to residual CHCl3 (7.27 ppm) or (CD3)(CD2H)SO 
(2.50 ppm) and 13C NMR spectra were referenced to CDCl3 (77.0 ppm) 
or DMSO-d6 (39.5 ppm). 
11B spectra were referenced to BF3·OEt2 at 0 
ppm, and 19F spectra were referenced to CFCl3 at 0 ppm. Mass 
spectrometry data were recorded in positive-ion mode using a high-
resolution Finnigan MAT 8200 spectrometer using electron impact 
ionization. UV-vis spectra were recorded using a Cary 300 Scan 
instrument. Molar extinction coefficients were determined from the slope 
of a plot of absorbance against concentration using four solutions with 
known concentrations ranging between 10 and 100 M. Infrared spectra 
were recorded on a KBr disk using a Bruker Vector 33 FT-IR 
spectrometer. Emission spectra were obtained using a Photon 
Technology International QM-4 SE spectrofluorometer. Excitation 
wavelengths were chosen based on absorption maxima from the 
respective UV-vis spectrum in the same solvent. Quantum yields were 
calculated relative to ruthenium tris(bipyridine) hexafluorophosphate by 
methods described by Fery-Forgues and co-workers.[22] 
 
Electrochemical Methods 
 
Cyclic voltammetry experiments were performed with a Bioanalytical 
Systems Inc. (BASi) Epsilon potentiostat and analyzed using BASi 
Epsilon software. Typical electrochemical cells consisted of a three-
electrode setup including a silver pseudo reference electrode, glassy 
carbon working electrode, and platinum counter electrode. Experiments 
were run at 100 mV s1 scan rate in degassed acetonitrile solutions of the 
analyte (1 mM) and electrolyte (0.1 M tetrabutylammonium 
hexafluorophosphate). Cyclic voltammograms were referenced relative to 
the ferrocene/ferrocenium redox couple (1 mM internal standard) and 
corrected for internal cell resistance using the BASi Epsilon software. 
 
X-ray Crystallography Methods 
 
Single crystals of 7a and 7b were mounted on a Mitegen polyimide 
micromount with a small amount of Paratone N oil. X-ray diffraction 
measurements for 7a were made on a Nonius KappaCCD Apex2 and 
measurements for 7b were made using Bruker a Kappa Axis Apex2 
diffractometer. Both compounds were measured at a temperature of 110 
K. The data collection strategy was a number of ω and φ which collected 
data over a range of angles, 2θ. The frame integration was performed 
using SAINT.[23] The resulting raw data was scaled and absorption 
corrected using a multi-scan averaging of symmetry equivalent data 
using SADABS.[24]  
   The structures were solved by using a dual space methodology using 
the SHELXT program.[25] All non-hydrogen atoms were obtained from the 
initial solution. The hydrogen atoms were introduced at idealized 
positions and were allowed to refine isotropically. The structural model 
was fit to the data using full matrix least-squares based on F2. The 
calculated structure factors included corrections for anomalous 
dispersion from the usual tabulation. The structures were refined using 
the SHELXL-2014 program from the SHELXTL program package.[26] See 
Table 4, the Supporting Information, and CCDC 1413166 and 1413167 
for crystallographic details. 
 
Table 4. X-ray diffraction data collection and refinement details for 7a and 7b. 
 
 7a 7b 
Chemical Formula C16H14BF2N5O2 C16H14BF2N5O2 
FW (g mol
1
) 357.13 357.13 
Crystal Dimensions 
(mm) 
0.411 × 0.149 × 0.104 0.384 × 0.324 × 0.246 
Crystal Habit red needle purple prism 
Crystal System monoclinic monoclinic 
Space Group P21/c C2/m 
Temperature (K) 110 110 
a (Å) 9.784(2) 13.349(3) 
b (Å) 18.259(5) 16.206(3) 
c (Å) 10.150(2) 8.1753(19) 
α (°) 90 90 
β (°) 111.382(6) 112.872(10) 
γ (°) 90 90 
V (Å
3
) 1688.4(7) 1629.6(6) 
Z 4 4 
ρ (g cm
3
) 1.405 1.456 
, Å 1.54178 (CuK) 0.71073 (MoK) 
μ (cm
1
) 0.938 0.114 
Diffractometer Type 
Nonius KappaCCD 
Apex2 
Bruker Kappa Axis 
Apex2 
Rmerge 0.0380 0.0272 
R1 [I > 2(I)] 0.0305 0.0387 
R2 [I > 2(I)] 0.0731 0.1127 
R1 (all data) 0.0376 0.0509 
R2 (all data) 0.0768 0.1210 
GOF 1.054 1.058 
R1 = Σ(|Fo|  |Fc|) / ΣFo; R2 = [Σ(( Fo
2
  Fc
2
 )
2
) / Σ(Fo
4
)]
½
; GOF = [Σ(( Fo
2
  
Fc
2
 )
2
) / (No. of reflns.  No. of params.)]
½ 
 
Cell Imaging Protocols 
 
A stock solution of BF2 formazanate complex 7c in DMSO (10 µM) was 
prepared and subsequently diluted with Dulbecco's modified Eagle's 
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medium (DMEM) to obtain final concentrations of 0.5 µM of dye. Mouse 
fibroblast C3H/10T1/2 cells (ATCC, Manassas, VA) were released from 
the tissue culture flask by trypsinization and seeded onto cover slips in a 
12-well tissue culture plate at an approximate cell density of 50,000 cells 
per well. The cells were incubated overnight in DMEM containing 10% 
fetal bovine serum (FBS) at 37 C in a 5% CO2 atmosphere. The serum 
containing DMEM in each well was removed and replaced with serum 
free DMEM containing a concentration of 0.5 µM of dye and incubated at 
37 C for 1 h. The cells were then washed three times with phosphate 
buffer saline (PBS), fixed with 4% paraformaldehyde and mounted onto 
slides containing Pro-Long Antifade mounting medium with DAPI. Images 
were then obtained using an Olympus FluoView FV 1000 confocal 
microscope.   
 
Representative Procedure for the Preparation of Formazans 4a, 4b, 
and 4d 
 
Formazan 4a (Ar1 = Ar5 = o-anisole, R3 = CN). In air, cyanoacetic acid 
(2.40 g, 28.2 mmol) and sodium hydroxide (11.4 g, 285 mmol) were 
dissolved in deionized water (140 mL). The resulting colorless solution 
was cooled to 0 °C and stirred for 2 h. In a separate flask, o-anisidine 
(6.92 g, 56.2 mmol) was combined with concentrated hydrochloric acid 
(14.0 mL, 168 mmol) in deionized water (55 mL) and stirred for 1.5 h at 
0 °C. A solution of sodium nitrite (5.83 g, 84.5 mmol) in deionized water 
(17 mL) was cooled to 0 °C in an ice bath for 1.5 h before it was added 
dropwise to the o-anisidine solution over a 25 min period. The resulting 
yellow-brown diazonium salt solution was stirred for 1 h at 0 °C before it 
was added to the alkaline cyanoacetic acid solution. Upon addition, the 
solution turned blood red and a precipitate of the same color formed. The 
mixture was left to warm slowly with stirring for 18 h before the solid was 
isolated by vacuum filtration. The filtrate was neutralized with 1 M HCl (ca. 
150 mL), extracted into dichloromethane (3 × 150 mL), washed with 
deionized water (3 × 150 mL), dried over MgSO4, gravity filtered, and 
concentrated in vacuo to afford a red solid. The crude solids were 
combined and purified by flash column chromatography 
(dichloromethane, neutral alumina) and recrystallized from a saturated 
methanolic solution to afford formazan 4a as red needles. Yield = 6.10 g, 
70%. M.p. 136−138 °C. 1H NMR (599.5 MHz, CDCl3):  13.91 (s, 1H, 
NH), 7.78 (d, 3JHH= 8 Hz, 2H, aryl CH), 7.34−7.31 (m, 2H, aryl CH), 
7.06−7.02 (m, 4H, aryl CH), 4.00 (s, 6H, OCH3). 
13C{1H} NMR (150.8 
MHz, CDCl3): 152.5, 136.1, 130.0, 121.4, 116.5, 116.5, 116.1, 112.0, 
56.1. FTIR (KBr): 3074 (m), 3027 (m), 2970 (m), 2944 (m), 2840 (m), 
2224 (s), 1584 (s), 1485 (s), 1482 (s), 1258 (s), 1024 (s) cm1. UV-vis 
(toluene): max 448 nm (ε = 19,700 M
1 cm1). MS (EI = +ve mode): exact 
mass calculated for [C16H15N5O2]
+: 309.1226; exact mass found: 
309.1238; difference: +3.9 ppm. 
 
Formazan 4b (Ar1 = Ar5 = m-anisole, R3 = CN). From 3.41 g (27.7 
mmol) of m-anisidine. Yield = 0.751 g, 18% of a dark red microcrystalline 
solid. M.p. 132−134 °C. 1H NMR (599.5 MHz, CDCl3): Open Isomer 
(major, 75%)  12.89 (s, 1H, NH), 7.37 (t, 3JHH = 8 Hz, 2H, aryl CH), 
7.22−7.21 (m, 2H, aryl CH), 7.19−7.17 (m, 2H, aryl CH), 6.92 (dd, 3JHH = 
8 Hz, 4JHH = 3 Hz, 2H, aryl CH), 3.89 (s, 6H, OCH3); Linear Isomer (minor, 
25%)  9.14 (s, 1H, NH), 7.53 (d, 3JHH = 8 Hz, 1H, aryl CH), 7.43−7.40 (m, 
3H, aryl CH), 7.33−7.30 (m, 1H, aryl CH), 7.07−7.06 (m, 1H, aryl CH), 
7.02 (m, 1H, aryl CH), 6.74−6.73 (m, 1H, aryl CH), 3.89 (s, 3H, OCH3), 
3.88 (s, 3H, OCH3). 
13C{1H} NMR (150.8 MHz, CDCl3):  161.0, 160.8, 
160.4, 153.2, 147.5, 142.0, 130.5, 130.3, 130.3, 129.9, 125.1, 119.2, 
117.7, 115.7, 114.4, 113.0, 111.2, 108.0, 107.9, 105.6, 103.5, 100.9, 
55.6 (br). FTIR (KBr): 3276 (m), 3086 (m), 3008 (m), 2960 (m), 2839 (m), 
2227 (s), 1609 (s), 1535 (s), 1496 (s), 1412 (m), 1240 (s), 1150 (m), 1044 
(s) cm1. UV-vis (toluene): max 432 nm (ε = 20,150 M
1 cm1). MS (EI = 
+ve mode): exact mass calculated for [C16H15N5O2]
+: 309.1226; exact 
mass found: 309.1221; difference: −1.6 ppm. 
 
Formazan 4d (Ar1 = Ar5 = o-ethylbenzene, R3 = CN). From 2.96 g (24.4 
mmol) of 2-ethylaniline. Yield = 0.322 g, 9% of a dark red powder. M.p. 
89−91 °C. 1H NMR (599.5 MHz, CDCl3): Open Isomer (major, 81%)  
11.75 (s, 1H, NH), 7.67−7.65 (m, 2H, aryl CH), 7.34−7.31 (m, 6H, aryl 
CH), 2.97 (q, 3JHH = 8 Hz, 4H, CH2CH3), 1.35 (m, 6H, CH2CH3); Linear 
Isomer (minor, 29%)  9.17 (s, 1H, NH), 7.77 (d, 3JHH = 8 Hz, 1H, aryl 
CH), 7.72 (m, 1H, aryl CH), 7.44 (m, 2H, aryl CH), 7.40 (m, 2H, aryl CH), 
7.30−7.28 (m, 1H, aryl CH), 7.15 (m, 1H, CH), 3.18 (q, 3JHH = 8 Hz, 4H, 
CH2CH3), 2.80 (q, 
3JHH = 8 Hz, 2H, CH2CH3), 1.39 (m, 6H, CH2CH3). 
13C{1H} NMR (150.8 MHz, CDCl3):  149.3, 145.3, 144.2, 138.1, 137.8, 
132.3, 131.9, 130.0, 129.6, 129.5, 129.1, 129.0, 127.6, 127.4, 127.2, 
126.5, 124.8, 115.6, 115.5, 115.4, 113.3, 108.0, 24.7, 24.2, 23.5, 16.3, 
15.0, 13.8. FTIR (KBr): 3338 (m), 3077 (m), 2973 (m), 2936 (m), 2878 
(m), 2227 (m), 1589 (m), 1529 (s), 1457 (m), 1276 (m), 1201 (m), 1157 
(m), 1060 (w) cm1. UV-vis (toluene): max 419 nm (ε = 25,500 M
1 cm1). 
MS (EI = +ve mode): exact mass calculated for [C18H19N5]
+: 305.1640; 
exact mass found: 305.1639; difference: −0.3 ppm.  
 
Representative Procedure for the Preparation of Formazans 5a and 
5b 
 
Formazan 5a (Ar1 = Ar5 = o-anisole, R3 = NO2). The following 
procedure was adapted from a protocol developed by von Eschwege and 
co-workers.[19b] In air, o-anisidine (3.63 g, 29.5 mmol) was added to 
deionized water (28 mL) containing concentrated hydrochloric acid (16.0 
mL, 192 mmol). The mixture was cooled to −10 °C in an acetone/ice bath 
and stirred for 1 h. In a separate flask, sodium nitrite (3.22 g, 46.7 mmol) 
was dissolved in deionized water (9.20 mL) and cooled to −10 °C in an 
acetone/ice bath for 30 min. The sodium nitrite solution was added to the 
o-anisidine mixture dropwise over the course of 30 min. The resulting 
yellow-brown diazonium salt solution was then added to a flask 
containing sodium acetate (28.5 g, 347 mmol), glacial acetic acid (29.0 
mL) and deionized water (14 mL) and stirred at room temperature for 5 
min. Nitromethane (8.98 g, 7.97 mL, 147 mmol) was then added and the 
solution was stirred for 1 h before deionized water (1.60 L) was added. 
The solution was stirred for an additional 30 min and vacuum filtered to 
afford a red solid. The filtrate was extracted into dichloromethane (3 × 
250 mL), washed with deionized water (4 × 200 mL), dried over MgSO4, 
gravity filtered and concentrated in vacuo to afford a dark red solid. The 
crude solids were combined and purified by flash column 
chromatography (dichloromethane, neutral alumina) to afford formazan 
5a as a dark red microcrystalline solid. Yield = 4.01 g, 82%. M.p. 
176−178 °C. 1H NMR (599.5 MHz, CDCl3):  14.87 (s, 1H, NH), 
7.97−7.95 (m, 2H, aryl CH), 7.38−7.35 (m, 2H, aryl CH), 7.08−7.05 (m, 
2H, aryl CH), 7.04−7.03 (m, 2H, aryl CH), 4.02 (s, 6H, OCH3). 
13C{1H} 
NMR (150.8 MHz, CDCl3):  153.0, 136.2, 130.8, 121.6, 117.0, 112.0, 
56.1. FTIR (KBr): 3057 (m), 2990 (m), 1660 (m), 1578 (s), 1423 (m), 
1267 (m), 897 (m) cm1. UV-vis (toluene): max 472 nm (ε = 8,000 M
1 
cm1). MS (EI = +ve mode): exact mass calculated for [C15H15N5O4]
+: 
329.1124; exact mass found: 329.1121; difference: −0.9 ppm. 
 
Formazan 5b (Ar1 = Ar5 = m-anisole, R3 = NO2). From 2.19 g (17.8 
mmol) of m-anisidine. Yield = 1.77 g, 60% of dark red microcrystalline 
solid. M.p. 134−136 °C. 1H NMR (599.5 MHz, CDCl3):  15.08 (s, 1H, 
NH), 7.35 (t, 3JHH = 8 Hz, 2H, aryl CH), 7.24−7.23 (m, 2H, aryl CH), 
7.21−7.19 (m, 2H, aryl CH), 6.92 (dd, 3JHH = 8 Hz, 
4JHH = 2 Hz 2H, aryl 
CH), 3.85 (s, 6H, OCH3). 
13C{1H} NMR (150.8 MHz, CDCl3):  160.8, 
147.2, 130.3, 116.4, 113.8, 103.3, 55.5. FTIR (KBr): 3058 (m), 3018 (m), 
2973 (m), 2858 (m), 1661 (m), 1610 (s) 1552 (m), 1493 (w), 1434 (w), 
1360 (w), 1267 (s), 1143 (w), 1045 (w), 896 (w), 826 (s) cm1. UV-vis 
(toluene): max 466 nm (ε = 21,200 M
1 cm1). MS (EI = +ve mode): exact 
mass calculated for [C15H15N5O4]
+: 329.1124; exact mass found: 
329.1118; difference: −1.8 ppm. 
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Preparation of Formazan 5c (Ar1 = Ar5 = p-anisole, R3 = NO2). In air, 
nitromethane (1.23 g, 1.08 mL, 20.0 mmol) was combined with deionized 
water (150 mL), and sodium hydroxide (1.76 g, 44.0 mmol) before the 
mixture was cooled to 0 °C in an ice bath. In a separate flask, p-anisidine 
(5.00 g, 41.0 mmol) and concentrated hydrochloric acid (11.1 mL, 133 
mmol) were mixed with deionized water (15 mL) and cooled to 0 °C in an 
ice bath. A cooled solution (0 C) of sodium nitrite (3.35 g, 49.0 mmol) in 
deionized water (10 mL) was added slowly to the amine solution. This 
mixture was left to stir at 0 °C for 30 min, at which time the dark yellow 
diazonium salt solution was added dropwise to the nitromethane solution 
described above over a 10 min period. The resulting mixture was left to 
warm slowly with stirring for 18 h, during which time a dark red precipitate 
had formed. The dark red solid was isolated by vacuum filtration and 
purified by flash column chromatography (dichloromethane, neutral 
alumina) to afford formazan 5c as a dark red microcrystalline solid. Yield 
= 6.59 g, 55%. M.p. 162−164 °C. 1H NMR (599.5 MHz, DMSO-d6):  
14.61 (s, 1H, NH), 7.86 (d, 3JHH = 8 Hz, 4H, aryl CH), 7.11 (d, 
3JHH = 8 Hz, 
4H, aryl CH), 3.85 (s, 6H, OCH3). 
13C{1H} NMR (150.8 MHz, DMSO-d6):  
160.5, 140.1, 121.8, 114.9, 55.7. FTIR (KBr): 3061 (m), 3018 (m), 2995 
(m), 1659 (m), 1574 (w), 1428 (m), 1348 (w), 1268 (s), 1159 (w), 899 (m), 
745 (m) cm1. UV-vis (toluene): max 504 nm (ε = 18,400 M
1 cm1). MS 
(EI, +ve mode): exact mass calculated for [C15H15N5O4]
+: 329.1124; exact 
mass found: 329.1123; difference: −0.3 ppm. 
 
Representative Procedure for Preparation of Formazans 6ac 
 
Formazan 6a (Ar1 = Ar5 = o-anisole, R3 = Ph). In air, phenylpyruvic acid 
(1.0 g, 6.1 mmol) and sodium hydroxide (1.83 g, 45.7 mmol) were 
combined with deionized water (150 mL) and cooled to 0 °C in an ice 
bath for 30 min. In a separate flask, o-anisidine (1.50 g, 12.2 mmol) and 
concentrated hydrochloric acid (3.5 mL, 42 mmol) were mixed in 
deionized water (10 mL), and cooled to 0 °C in an ice bath for 10 min. A 
cooled solution (0 C) of sodium nitrite (0.97 g, 14.0 mmol) in deionized 
water (5 mL) was added slowly to the amine solution over a 10 min 
period. This yellow mixture was left to stir at 0 °C for 30 min, at which 
time it was added dropwise to the phenylpyruvic acid reaction mixture 
described above over a 10 min period. The resulting solution was left to 
warm slowly with stirring for 18 h, at which time a purple precipitate had 
formed. The purple solid was isolated by filtration and purified by flash 
column chromatography (dichloromethane, neutral alumina) to afford 
formazan 6a as a purple microcrystalline solid. Yield = 1.98 g, 90%. M.p. 
120–122 °C. 1H NMR (599.5 MHz, CDCl3): δ 15.01 (s, 1H, NH), 
8.24−8.23 (m, 2H, aryl CH), 7.98−7.97 (m, 2H, aryl CH), 7.49−7.46 (m, 
2H, aryl CH), 7.38−7.36 (m, 1H, aryl CH), 7.28−7.25 (m, 2H, aryl CH), 
7.10−7.07 (m, 2H, aryl CH), 7.04−7.02 (m, 2H, aryl CH), 4.02 (s, 6H, 
OCH3). 
13C{1H} NMR (100.6 MHz, CDCl3): δ 152.0, 142.2, 138.0, 137.9, 
128.3, 128.0, 127.3, 125.8, 121.3, 115.7, 111.7, 56.0. FT-IR (KBr): 3076 
(m), 3008 (m), 2915 (m), 1659 (m), 1267 (m), 1106 (s), 752 (m) cm−1. 
UV-vis (toluene): λmax = 507 nm (ε = 22,900 M
1 cm1). Mass Spec. (EI, 
+ve mode): exact mass calculated for [C21H20N4O2]
+: 360.1586; exact 
mass found: 360.1580; difference: −1.7 ppm. 
 
Formazan 6b (Ar1 = Ar5 = m-anisole, R3 = Ph). From 1.50 g (12.2 
mmol) of m-anisidine. Yield = 1.38 g, 63% as a dark red solid. M.p. 99–
101 °C. 1H NMR (599.5 MHz, CDCl3): δ 15.35 (s, 1H, NH), 8.15−8.14 (m, 
2H, aryl CH), 7.48−7.46 (m, 2H, aryl CH), 7.39−7.36 (m, 3H, aryl CH), 
7.31 (s, 2H, aryl CH), 7.24−7.23 (m, 2H, aryl CH), 6.87−6.85 (m, 2H, aryl 
CH), 3.91 (s, 6H, OCH3). 
13C{1H} NMR (100.6 MHz, CDCl3): δ 160.7, 
149.1, 141.0, 137.3, 130.0, 128.4, 127.6, 125.8, 113.4, 112.6, 102.9, 
55.4. FTIR (KBr): 3057 (m), 2991 (m), 1660 (m), 1643 (m), 1426 (m), 
1268 (s), 1103 (s), 898 (m), 745 (m) cm−1. UV-vis (toluene): λmax = 496 
nm (ε = 21,600 M−1 cm−1). Mass Spec. (EI, +ve mode): exact mass 
calculated for [C21H20N4O2]
+: 360.1586; exact mass found: 360.1584; 
difference: −0.6 ppm. 
 
Formazan 6c (Ar1 = Ar5 = p-anisole, R3 = Ph). From 1.48 g (12.0 mmol) 
of p-anisidine. Yield = 1.69 g, 82% as a dark red solid. M.p. 122–124 °C. 
1H NMR (599.5 MHz, CDCl3): δ 15.56 (s, 1H, NH), 8.13 (d, 
3JHH = 7 Hz, 
2H, aryl CH), 7.65 (d, 3JHH = 9 Hz, 4H, aryl CH), 7.45–7.43 (m, 2H, aryl 
CH), 7.34 (t, 3JHH = 8 Hz, 1H, aryl CH), 6.99 (d, 
3JHH = 9 Hz, 4H, aryl CH), 
3.88 (s, 6H, OCH3). 
13C{1H} NMR (100.6 MHz, CDCl3): δ 159.2, 142.0, 
140.6, 137.8, 128.3, 127.2, 125.6, 120.0, 114.7, 55.6. FTIR (KBr): 3263 
(br, s), 2984 (m), 2884 (w), 2794 (s), 1594 (s), 1573 (m), 1507 (s), 1495 
(s), 1226 (s), 1176 (m) cm−1. UV-vis (toluene): λmax = 530 nm (ε = 23,400 
M−1 cm−1). Mass Spec. (EI, +ve mode): exact mass calculated for 
[C21H20N4O2]
+: 360.1586; exact mass found: 360.1581; difference: −1.4 
ppm. 
 
Representative Procedure for the Preparation of Formazanate BF2 
Complexes 7a and 7d.  
 
Formazanate BF2 Complex 7a (Ar1 = Ar5 = o-anisole, R3 = CN). 
Formazan 4a (0.500 g, 1.61 mmol) was dissolved in toluene (250 mL) 
before triethylamine (1.45 g, 2.00 mL, 14.2 mmol) was added and the 
solution stirred for 30 min. Boron trifluoride diethyl etherate (3.45 g, 3.00 
mL, 24.3 mmol) was then added and the solution heated to 105 °C for 36 
h. During this time, the solution gradually changed color from dark red to 
red-orange. The solution was cooled to 20 °C and deionized water (25 
mL) was added to quench any remaining reactive species. The mixture 
was then washed with deionized water (3 × 50 mL), dried over MgSO4, 
gravity filtered, and concentrated in vacuo to afford 7a as a red-orange 
solid. The crude solid was purified via flash column chromatography 
(dichloromethane, neutral alumina) to afford 7a as a bright orange 
powder. This compound hydrolyzes slowly. Analyses were performed 
using dry solvents. Yield = 0.353 g, 61%. M.p. 134−136 °C. 1H NMR 
(599.5 MHz, dry CDCl3):  7.46−7.43 (m, 2H, aryl CH), 7.30−7.28 (m, 2H, 
aryl CH), 7.05−7.01 (m, 4H, aryl CH), 3.91 (s, 6H, OCH3). 
13C{1H} NMR 
(150.8 MHz, CDCl3):  154.8, 132.5, 132.4, 127.2, 120.8, 113.8, 112.8, 
56.4. 11B NMR (128.3 MHz, CDCl3):  −1.9 (t, 
1JBF = 20 Hz). 
19F NMR 
(376.1 MHz, CDCl3):  −154.3 (q, 
1JFB = 19 Hz). FTIR (KBr): 3072 (m), 
3017 (m), 2960 (m), 2853 (m), 2237 (s), 1605 (s), 1488 (s), 1340 (s), 
1260 (s), 1195 (s), 1164 (s), 1030 (s) cm1. UV-vis (toluene): max 467 nm 
(ε = 16,000 M1 cm1). MS (EI = +ve mode): exact mass calculated for 
[C16H14BF2N5O2]
+: 357.1209; exact mass found: 357.1212; difference: 
+0.8 ppm. 
 
Formazanate BF2 Complex 7d (Ar1 = Ar5 = o-ethylbenzene, R3 = CN). 
From 0.366 g (1.20 mmol) of formazan 4d. Yield = 0.095 g, 22% of dark 
orange oil. 1H NMR (599.5 MHz, CDCl3):  7.47−7.45 (m, 2H, aryl CH), 
7.42−7.39 (m, 4H, aryl CH), 7.34−7.31 (m, 2H, aryl CH), 2.65 (q, 3JHH = 8 
Hz, 4H, CH2CH3), 1.24 (t, 
3JHH = 7 Hz, 6H, CH2CH3). 
13C{1H} NMR (150.8 
MHz, CDCl3):  140.9, 139.7, 131.0, 130.5, 126.6, 126.3, 113.4, 24.3, 
14.9. 11B NMR (128.3 MHz, CDCl3):  −1.9 (t, 
1JBF = 24 Hz). 
19F (376.1 
MHz, CDCl3):  −146.9 (q, 
1JFB = 24 Hz). FTIR (KBr): 3077 (m), 2975 (s), 
2938 (s), 2879 (m), 2247 (m), 1453 (s), 1336 (s), 1217 (s), 1084 (s), 1025 
(s), 970 (s) cm1. UV-vis (toluene): max 436 nm (ε = 14,000 M
1 cm1). 
MS (EI = +ve mode): exact mass calculated for [C18H18BF2N5]
+: 
353.1623; exact mass found: 353.1626; difference: +0.8 ppm. 
 
Representative Procedure for the Preparation of Formazanate BF2 
Complexes 7b, 8b,c, and 9ac 
 
Formazanate BF2 Complex 7b (Ar1 = Ar5 = m-anisole, R3 = CN). 
Formazan 4b (0.398 g, 1.28 mmol) was dissolved in toluene (175 mL) 
before triethylamine (0.391 g, 0.540 mL, 3.86 mmol) was added and the 
solution stirred for 30 min. Boron trifluoride diethyl etherate (0.92 g, 0.80 
mL, 6.5 mmol) was then added and the solution heated to 80 °C for 18 h. 
During this time, the solution gradually changed color from dark red to 
purple. The solution was cooled to 20 °C and deionized water (15 mL) 
was added to quench any remaining reactive species. The mixture was 
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then washed with deionized water (3 × 50 mL), dried over MgSO4, gravity 
filtered, and concentrated in vacuo to afford 7b as a purple solid. The 
crude solid was purified via flash column chromatography 
(dichloromethane, neutral alumina) and recrystallized from a saturated 
methanolic solution to afford 7b as a purple microcrystalline solid. Yield = 
0.221 g, 48%. M.p. 143−145 °C. 1H NMR (599.5 MHz, CDCl3):  7.55 (d, 
3JHH = 9 Hz, 2H, aryl CH), 7.42−7.40 (m, 4H, aryl CH), 7.08 (dd, 
3JHH = 8 
Hz, 4JHH = 3 Hz, 2H, aryl CH), 3.89 (s, 6H, OCH3). 
13C{1H} NMR (150.8 
MHz, CDCl3):  160.4, 144.1, 130.2, 118.2, 116.0 (t, 
4JCF = 3 Hz), 114.0, 
107.6, 55.7. 11B NMR (128.3 MHz, CDCl3):  −0.8 (t, 
1JBF = 31 Hz). 
19F 
(376.1 MHz, CDCl3):  −132.6 (q, 
1JFB = 29 Hz). FTIR (KBr): 3072 (m), 
3016 (m), 2958 (m), 2850 (m), 2237 (s), 1605 (s), 1582 (s), 1487 (s), 
1456 (m), 1339 (s), 1293 (m), 1260 (s), 1195 (m), 1164 (m), 1031 (s) 
cm1. UV-vis (toluene): max 525 nm (ε = 21,100 M
1 cm1). MS (EI = +ve 
mode): exact mass calculated for [C16H14BF2N5O2]
+: 357.1209; exact 
mass found: 357.1198; difference: −3.1 ppm. 
 
Formazanate BF2 Complex 8b (Ar1 = Ar5 = m-anisole, R3 = NO2). From 
0.398 g (1.21 mmol) of formazan 5b. Yield = 0.111 g, 24% of dark purple 
microcrystalline solid. M.p. 78−80 °C. 1H NMR (599.5 MHz, CDCl3):  
7.64−7.62 (m, 2H, aryl CH), 7.52−7.50 (m, 2H, aryl CH), 7.43 (t, 3JHH = 8 
Hz, 2H, aryl CH), 7.09 (dd, 3JHH = 8 Hz, 
4JHH = 2 Hz, 2H, aryl CH), 3.90 (s, 
6H, OCH3). 
13C{1H} NMR (150.8 MHz, CDCl3):  160.5, 144.2, 130.3, 
118.5, 116.3 (4JCF = 4 Hz), 108.0, 55.7. 
11B NMR (128.3 MHz, CDCl3):  
−0.7 (t, 1JBF = 29 Hz). 
19F (376.1 MHz, CDCl3):  −134.6 (q, 
1JFB = 29 Hz). 
FTIR (KBr): 3076 (m), 3013 (m), 2863 (m), 1658 (m), 1580 (m), 1424 (m), 
1266 (m), 1095 (s), 745 (m) cm1. UV-vis (toluene): max 533 nm (ε = 
18,400 M1 cm1). MS (EI = +ve mode): exact mass calculated for 
[C15H14BF2N5O4]
+: 377.1107; exact mass found: 377.1104; difference: 
−0.8 ppm. 
 
Formazanate BF2 Complex 8c (Ar1 = Ar5 = p-anisole, R3 = NO2). From 
1.19 g (3.60 mmol) of formazan 5c. Yield = 0.291 g, 21% of dark purple 
microcrystalline solid. M.p. 154−156 °C. 1H NMR (599.5 MHz, CDCl3):  
7.99 (d, 3JHH = 9 Hz, 4H, aryl CH), 7.01 (dd, 
3JHH = 9 Hz, 
4JHH = 2 Hz, 4H, 
aryl CH), 3.91 (s, 6H, OCH3). 
13C{1H} NMR (150.8 MHz, CDCl3):  162.4, 
137.0, 125.2, 114.9, 100.0, 55.8. 11B NMR (128.3 MHz, CDCl3):  −0.7 (t, 
1JBF = 30 Hz). 
19F (376.1 MHz, CDCl3):  −137.1 (q, 
1JFB = 29 Hz). FTIR 
(KBr): 3058 (m), 3011 (m), 2993 (m), 1656 (m), 1580 (w), 1420 (m), 1340 
(w), 1270 (s), 1151 (w), 900 (m), 745 (m) cm1. UV-vis (toluene): max 579 
nm (ε = 23,600 M1 cm1). MS (EI = +ve mode): exact mass calculated 
for [C15H14BF2N5O4]
+: 377.1107; exact mass found: 377.1101; difference: 
−1.6 ppm. 
 
Formazanate BF2 Complex 9a (Ar1 = Ar5 = o-anisole, R3 = Ph). This 
complex required additional purification by flash column chromatography 
(toluene, silica gel). From 0.396 g (1.10 mmol) of formazan 6a. Yield = 
0.212 g, 47% of an orange solid. M.p. 158–160 °C. 1H NMR (399.5 MHz, 
CDCl3): δ 8.088.06 (m, 2H, aryl CH), 7.467.38 (m, 5H, aryl CH), 
7.237.22 (m, 2H, aryl CH), 7.046.99 (m, 4H, aryl CH), 3.92 (s, 6H, 
OCH3). 
13C{1H} NMR (100.6 MHz, CDCl3): δ 155.0, 151.5, 133.3, 133.1, 
130.9, 129.2, 128.5, 127.3, 125.7, 120.6, 112.5, 56.3. 11B NMR (128.3 
MHz, CDCl3): δ −1.2 (t, 
1JBF = 19 Hz).
 19F NMR (376.1 MHz, CDCl3): δ 
−160.6 (q, 1JFB = 19 Hz). FTIR (KBr): 3057 (m), 2988 (m), 2967 (w), 2843 
(m), 1666 (m), 1496 (s), 1441 (m), 1359 (m), 1268 (s), 1124 (s), 1050 
(m), 897 (m), 745 (m) cm−1. UV-vis (toluene): λmax 467 nm (ε = 18,800 
M1 cm1). Mass Spec. (EI, +ve mode): exact mass calculated for 
[C21H19BF2N4O2]
+: 408.1569; exact mass found: 408.1564; difference: 
−1.2 ppm.  
 
Formazanate BF2 Complex 9b (Ar1 = Ar5 = m-anisole, R3 = Ph). From 
0.613 g (1.70 mmol) of formazan 6b. Yield = 0.621 g, 90% of a purple-
red solid. M.p. 76–78 °C.  1H NMR (399.8 MHz, CDCl3): δ 8.148.13 (m, 
2H, aryl CH), 7.577.56 (m, 2H, aryl CH), 7.527.49 (m, 2H, aryl CH), 
7.477.46 (m, 3H, aryl CH), 7.417.39 (m, 2H, aryl CH), 7.027.01 (m, 
2H, aryl CH), 3.89 (s, 6H, OCH3). 
13C{1H} NMR (100.6 MHz, CDCl3): δ 
160.1, 148.9, 145.0, 133.5, 129.8, 129.3, 128.7, 125.5, 116.1 (m), 116.0, 
108.5, 55.5. 11B NMR (128.3 MHz, CDCl3): δ −0.6 (t, 
1JBF = 29 Hz).
 19F 
NMR (376.1 MHz, CDCl3): δ −144.2 (q, 
1JFB = 28 Hz). FTIR (KBr): 3058 
(m), 2989 (m),  2900 (m), 2841 (w), 1667 (m), 1605 (m), 1494 (m), 1424 
(m), 1357 (w), 1267 (s), 1119 (m), 897 (w), 745 (m) cm−1. UV-vis 
(toluene): λmax 530 nm (ε = 22,900 M
−1 cm−1). Mass Spec. (EI, +ve 
mode): exact mass calculated for [C21H19BF2N4O2]
+: 408.1569; exact 
mass found: 408.1570; difference: +0.2 ppm.  
 
Formazanate BF2 Complex 9c (Ar1 = Ar5 = p-anisole, R3 = Ph). From 
1.00 g (2.80 mmol) of formazan 6c. Yield = 0.711 g, 62% of a dark purple 
solid. M.p. 170172 °C. 1H NMR (399.8 MHz, CDCl3): δ 8.12 (d, 
3JHH
 = 7 
Hz, 2H, aryl CH), 7.88 (d, 3JHH
 = 9 Hz, 4H, aryl CH), 7.49−7.41 (m, 3H, 
aryl CH), 6.98 (d, 3JHH
 = 9 Hz, 4H, aryl CH), 3.88 (s, 6H, OCH3). 
13C{1H} 
NMR (100.6 MHz, CDCl3): δ 160.7, 137.6, 134.0, 128.9, 128.6, 125.4, 
124.9, 114.3, 55.6. 11B NMR (128.3 MHz, CDCl3): δ −0.4 (t, 
1JBF = 29 
Hz). 19F NMR (376.1 MHz, CDCl3): δ −145.3 (q, 
1JFB = 29 Hz). FTIR 
(KBr): 2948 (m), 2900 (m), 2834 (m), 1641 (s), 1596 (s), 1508 (s), 1313 
(m), 1249 (s), 1164 (s) cm−1. UV-vis (toluene): λmax 551 nm (ε = 25,500 
M−1 cm−1). Mass Spec. (EI, +ve mode): exact mass calculated for 
[C21H19BF2N4O2]
+: 408.1569; exact mass found: 408.1576; difference: 
+1.7 ppm. 
 
Preparation of Formazanate BF2 Complex 8a (Ar1 = Ar5 = o-anisole, 
R3 = NO2). Formazan 5a (1.00 g, 3.04 mmol) was dissolved in toluene 
(250 mL) before triethylamine (2.82 g, 3.90 mL, 27.9 mmol) was added 
and the solution stirred for 30 min. Boron trifluoride diethyl etherate (6.44 
g, 5.60 mL, 45.4 mmol) was added and the solution heated with stirring 
at 105 °C for 144 h at which time the solution was dark purple with a blue 
hue on the sides of the flask. The solution was cooled to 20 °C and 
poured directly onto a column containing neutral alumina. After the 
toluene solution was adsorbed onto the alumina, dichloromethane was 
used as the eluent. The crude product was isolated as a bright orange 
solution, which was washed with deionized water (3 × 1.00 L). The 
organic layer was collected, dried over MgSO4, gravity filtered, and 
concentrated in vacuo to afford 8a as a red-orange solid. The crude solid 
was purified via flash column chromatography (toluene, neutral alumina, 
Rf = 0.33) to afford 8a as a bright orange powder. Yield = 0.163 g, 15%. 
Mp = 166−168 °C. 1H NMR (599.5 MHz, CDCl3):  7.47 (t, 
3JHH = 8 Hz, 
2H, aryl CH), 7.36 (d, 3JHH = 8 Hz, 2H, aryl CH), 7.06−7.03 (m, 4H, aryl 
CH), 3.92 (s, 6H, OCH3). 
13C{1H} NMR (150.8 MHz, CDCl3):  155.0, 
132.9, 132.7, 127.3, 120.9 (2C), 112.9, 56.5. 11B NMR (128.3 MHz, 
CDCl3):  −1.6 (t, 
1JBF = 19 Hz). 
19F NMR (376.1 MHz, CDCl3):  −156.0 
(q, 1JFB = 18 Hz). FTIR (KBr): 3035 (m), 2974 (m), 2845 (m), 1660 (m), 
1587 (m), 1557 (m), 1494 (m), 1332 (m), 1260 (m), 1100 (s), 1021 (m), 
814 (m), 751 (m) cm1. UV-vis (toluene): max 468 nm (ε = 7,500 M
1 
cm1). MS (EI = +ve mode): exact mass calculated for [C15H14BF2N5O4]
+: 
377.1107; exact mass found: 377.1101; difference: −1.6 ppm. 
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Figure S1. 
1
H NMR spectrum of 4a in CDCl3. The asterisks denote residual solvent signals. 
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Figure S2. 
13
C{
1
H} NMR spectrum of 4a in CDCl3. The asterisk denotes solvent signal. 
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Figure S3. 
1
H NMR spectrum of 7a in CDCl3. The asterisk denotes residual solvent signal. 
 
Figure S4. 
13
C{
1
H} NMR spectrum of 7a in CDCl3. The asterisk denotes solvent signal. 
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Figure S5. 
1
H NMR spectrum of 4b in CDCl3. The asterisk denotes residual solvent signal. 
Figure S6. 
13
C{
1
H} NMR spectrum of 4b in CDCl3. The asterisk denotes solvent signal. 
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Figure S7. 
1
H NMR spectrum of 7b in CDCl3. The asterisk denotes residual solvent signal. 
Figure S8. 
13
C{
1
H} NMR spectrum of 7b in CDCl3. The asterisk denotes solvent signal. 
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Figure S9. 
1
H NMR spectrum of 4d in CDCl3. The asterisks denote residual solvent signals. 
Figure S10.
13
C{
1
H} NMR spectrum of 4d in CDCl3. The asterisk denotes solvent signal. 
*
 
S7 
 
 
 
  
 
 
*
 
*
 
Figure S11. 
1
H NMR spectrum of 7d in CDCl3. The asterisk denotes residual solvent signal. 
Figure S12. 
13
C{
1
H} NMR spectrum of 7d in CDCl3. The asterisk denotes solvent signal. 
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Figure S13. 
1
H NMR spectrum of 5a in CDCl3. The asterisks denote residual solvent signals. 
Figure S14. 
13
C{
1
H} NMR spectrum of 5a in CDCl3. The asterisk denotes solvent signal. 
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Figure S15. 
1
H NMR spectrum of 8a in CDCl3. The asterisks denote residual solvent signals. 
Figure S16. 
13
C{
1
H} NMR spectrum of 8a in CDCl3. The asterisk denotes solvent signal. 
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Figure S17. 
1
H NMR spectrum of 5b in CDCl3. The asterisk denotes residual solvent signal. 
Figure S18. 
13
C{
1
H} NMR spectrum of 5b in CDCl3. The asterisk denotes solvent signal. 
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Figure S19. 
1
H NMR spectrum of 8b in CDCl3. The asterisks denote residual solvent signals. 
Figure S20. 
13
C{
1
H} NMR spectrum of 8b in CDCl3. The asterisk denotes solvent signal. 
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Figure S21. 
1
H NMR spectrum of 5c in DMSO-d6. The asterisks denote residual solvent signals. 
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Figure S22. 
13
C{
1
H} NMR spectrum of 5c in DMSO-d6. The asterisk denotes solvent signal. 
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Figure S23. 
1
H NMR spectrum of 8c in CDCl3. The asterisks denote residual solvent signals. 
Figure S24. 
13
C{
1
H} NMR spectrum of 8c in CDCl3. The asterisk denotes solvent signal. 
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Figure S25. 
1
H NMR spectrum of 6a in CDCl3. The asterisk denotes residual solvent signal. 
Figure S26. 
13
C{
1
H} NMR spectrum of 6a in CDCl3. The asterisk denotes solvent signal. 
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Figure S27. 
1
H NMR spectrum of 9a in CDCl3. The asterisks denote residual solvent signals. 
Figure S28. 
13
C{
1
H} NMR spectrum of 9a in CDCl3. The asterisk denotes solvent signal. 
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Figure S30. 
13
C{
1
H} NMR spectrum of 6b in CDCl3. The asterisk denotes solvent signal. 
Figure S29. 
1
H NMR spectrum of 6b in CDCl3. The asterisk denotes residual solvent signal. 
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Figure S31. 
1
H NMR spectrum of 9b in CDCl3. The asterisks denote residual solvent signals. 
Figure S32. 
13
C{
1
H} NMR spectrum of 9b in CDCl3. The asterisk denotes solvent signal. 
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Figure S34. 
13
C{
1
H} NMR spectrum of 6c in CDCl3. The asterisk denotes solvent signal. 
Figure S33. 
1
H NMR spectrum of 6c in CDCl3. The asterisk denotes residual solvent signal. 
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Figure S35. 
1
H NMR spectrum of 9c in CDCl3. The asterisks denote residual solvent and grease 
signals. 
Figure S36. 
13
C{
1
H} NMR spectrum of 9c in CDCl3. The asterisk denotes solvent signal. 
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Figure S38. Cyclic voltammograms for BF2 formazanate complexes 7a (Ar = o-anisole, R = 
cyano; black line), 7b (Ar = m-anisole, R = cyano; red line), 7c (Ar = p-anisole, R = cyano; blue 
line), and 7d (Ar = o-ethylbenzene, R = cyano; green line) recorded in dry, degassed acetonitrile 
containing ~1 mM analyte and 0.1 M n-Bu4NPF6 at a scan rate of 100 mV s
1
. 
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Figure S37. Solid-state packing of 7b. Dashed lines indicate shortest contact points 
between anisole rings (Å). 
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Figure S39. Cyclic voltammograms for BF2 formazanate complexes 8a (Ar = o-anisole, R = 
nitro; black line), 8b (Ar = m-anisole, R = nitro; red line), and 8c (Ar = p-anisole, R = nitro; blue 
line) recorded in dry, degassed acetonitrile containing ~1 mM analyte and 0.1 M n-Bu4NPF6 at a 
scan rate of 100 mV s
1
. 
 
 
Figure S40. Cyclic voltammograms for BF2 formazanate complexes 9a (Ar = o-anisole, R = 
phenyl; black line), 9b (Ar = m-anisole, R = phenyl; red line), and 9c (Ar = p-anisole, R = 
phenyl; blue line) recorded in dry, degassed acetonitrile containing ~1 mM analyte and 0.1 M   
n-Bu4NPF6 at a scan rate of 100 mV s
1
. 
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Potential (V vs. Ferrocene / Ferrocenium)
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50 μA
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Figure S41. Wavelength-dependent emission correction provided by Photon Technology 
International. 
 
 
 
 
Figure S42. UV-vis absorption spectra (a) and emission spectra (b) for BF2 formazanate 
complexes 7d (Ar = o-ethylbenzene, R = cyano) recorded for a degassed 10 M toluene solution.  
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Figure S43. UV-vis absorption spectra (a) and emission spectra (b) for BF2 formazanate 
complexes 8a (Ar = o-anisole, R = nitro; black line), 8b (Ar = m-anisole, R = nitro; red line), and 
8c (Ar = p-anisole, R = nitro; blue line) recorded for degassed 10
 M toluene solutions.  
 
 
 
 
 
 
 
Figure S44. UV-vis absorption spectra (a) and emission spectra (b) for BF2 formazanate 
complexes 9a (Ar = o-anisole, R = phenyl; black line), 9b (Ar = m-anisole, R = phenyl; red line), 
and 9c (Ar = p-anisole, R = phenyl; blue line) recorded for degassed 10 M toluene solutions. 
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Figure S45. UV-vis emission spectra for BF2 formazanate complexes 9c (Ar = p-anisole, R = 
phenyl) recorded for degassed 10 M tetrahydrofuran/water solutions containing 10% (black 
line), 25% (red line), 50% (blue line), and 75% (green line) v/v water. 
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